Osteoporosis Could Put Older Adults At Increased Risk Of Depression, Study Suggests

HCP Live (1/20, Derman) reported, “In addition to the increased risk of fracture, a new study suggests osteoporosis could put older adults at an increased risk of depression.” Investigators found that “individuals with osteoporosis had a 73% greater risk of experiencing depression symptoms than individuals without osteoporosis.” The findings were published in Public Health.

Related Links:

— “Osteoporosis Could Signal Increased Risk of Depression in Older Adults,” Chelsie Derman, HCP Live, January 20, 2024

People Coming Off Antidepressants Often Struggle With Emotional And Social Turmoil, Study Indicates

HealthDay (1/19, Thompson ) reported, “People coming off antidepressants often struggle with emotional and social turmoil, especially if they quit their meds cold turkey, a new study” indicated. The study, in which investigators “conducted interviews with 20 people who had attempted within the past year to withdraw from SSRI…antidepressants,” found that “challenges reported by patients quitting antidepressants included feeling overwhelmed by their emotions, finding social situations less enjoyable, and feeling detached and less empathetic towards others.”

The findings were published in Health Expectations.

Related Links:

— “Quick Withdrawal From Antidepressants Can Take Emotional, Cognitive Toll,” Dennis Thompson, HealthDay, January 19, 2024

In utero opioid exposure tied to greater risk for hospitalizations, ED visits for immune-related conditions

MedPage Today (1/18, Firth ) reports a study found that “opioid use during pregnancy for pain or opioid use disorder was associated with an increased risk for hospitalizations and emergency department (ED) visits for immune-related conditions in exposed offspring.” Among “more than 400,000 kids born in Western Australia, those with perinatal opioid exposure had an increased risk of perinatal infection…and eczema and dermatitis…compared with non-exposed children,” the research found. The findings were published in JAMA Network Open.

Related Links:

MedPage Today (requires login and subscription)

Administration finalizes rule requiring insurers to set time targets for prior authorization process

Reuters (1/17, Roy) reports the administration “on Wednesday finalized a rule requiring health insurers to set time targets for the prior authorization process for patients seeking approval for medical services under government-backed insurance plans.” CMS “said the rule will begin primarily in 2026.” The new “rule applies to health insurance companies providing government backed-insurance plans such as Medicare” and Medicaid.

The Hill (1/17, Weixel ) reports that under the final rule, “health insurers participating in Medicare Advantage, Medicaid or the ObamaCare exchanges will need to respond to expedited prior authorization requests within 72 hours, and standard requests within seven calendar days.” The new “rule requires all impacted payers to include a specific reason for denying a prior authorization request.” Payers “will also be required to publicly report prior authorization metrics.”

Modern Healthcare (1/17, Bennett, Subscription Publication) reports “the regulation will take effect 60 days after it formally appears in the Federal Register.” In a press release, AMA President Jesse M. Ehrenfeld, MD, MPH, said, “The American Medical Association applauds Centers for Medicare and Medicaid Services Administrator [Chiquita] Brooks-LaSure for heeding patients and the physician community in a final rule that makes important reforms in government-regulated health plans’ prior authorization programs for medical services.”

Related Links:

— “US govt sets rule meant to speed up insurance approvals,” Reuters, January 17, 2024

Daily Multivitamin May Slow Memory Loss Among Individuals 60 And Older, Research Finds

The Washington Post (1/18, Cimons) reports, “A daily multivitamin may slow memory loss among those 60 and older by about two years, according to a study” that “is the third in a series of studies assessing the cognitive effects of a daily multivitamin on older adults.”

Moreover, “a systematic review, or meta-analysis, of the three studies accompanying the most recent paper said their cumulative results were similar: The group taking a multivitamin was two years younger in memory function compared with the group taking a placebo.” The findings were published in the American Journal of Clinical Nutrition.

The New York Times (1/18, Callahan, Smith) and NBC News (1/18, Sullivan) also cover the story.

Related Links:

— “More evidence suggests a multivitamin may help slow memory loss,” Kaitlin Sullivan, NBC News, January 18, 2024

US Adults Reported The Greatest Anxiety About Inflation, A Recession, And Gun Violence Over The Past Year, Poll Finds

Psychiatric News (1/18) reports, “Over the past year, U.S. adults reported the greatest anxiety about inflation, a recession, and gun violence, according to analysis of monthly data collected from APA’s Healthy Minds Poll in 2023.” Data from “the December poll” indicated that “many adults (38%) reported being anxious about their mental health, which has been a consistent finding over the past year.”

Meanwhile, “forty-four percent of adults said they expect to experience the same level of stress at the start of 2024 as they did at the start of 2023, while a quarter of respondents expect to experience more stress.”

Related Links:

— “Healthy Minds Poll Provides Insight Into Americans’ Anxieties Over Past Year,” Psychiatric News, January 18, 2024

FDA extends shelf-life of naloxone hydrochloride nasal spray for OTC use to four years

HCPlive (1/17, Pine ) reports the FDA “has extended the shelf-life of 4 mg naloxone hydrochloride nasal spray (Narcan) for nonprescription, over-the-counter (OTC) use from 3 years to 4 years.”

The new “approval only applies to nasal spray products produced” after Wednesday. According to HCPlive, “the shelf-life of products produced and distributed prior to the announcement have not been affected; therefore prescribers, patients, and caregivers should continue to adhere to the expiration date printed on the product’s packaging and labeling.”

Related Links:

— “FDA Extends Shelf-Life for Naloxone Nasal Spray,” Lana Pine, HCP Live, January17 , 2024

Community Leaders Concerned About Rising Suicide Rate For Hispanic People In US

NBC News (1/17) reports, “The suicide rate for Hispanic people in the United States has increased significantly over the past decade,” and this “trend has community leaders worried: Even elementary school-aged Hispanic children have tried to harm themselves or expressed suicidal thoughts.”

A “lack of access to mental health care is a problem for all segments of society, particularly since the beginning of the pandemic. But minorities face added economic and societal obstacles, said Maria Oquendo, a past president of the American Psychiatric Association and a suicide researcher.”

Related Links:

— “Rising Latino suicide rates worry community leaders,” Molly Castle Work and Andy Miller, NBC News, January 17, 2024

Nearly 50K Veterans, Former Service Members Used Emergency Suicide Prevention Program In Its First Year, VA Says

The Hill (1/17, Sforza ) reports that on Wednesday, the Department of Veterans Affairs “announced…that 49,714 veterans and former service members took advantage of a new benefit that allowed them to go to any VA or non-VA health facility to get free emergency care if they were experiencing an acute suicidal crisis.”

The VA “said the benefit not only offered potentially life-saving health care, it saved more than $64 million in health care costs.” Additionally, “the department said the new policy allowed those experiencing a suicidal crisis to get necessary care, including emergency room visits, up to 30 days of inpatient or crisis residential care, up to 90 days of outpatient care and transportation costs.”

Related Links:

— “VA says nearly 50K veterans used emergency suicide prevention program in its first year,” Lauren Sforza, The Hill, January 17, 2024

Personal Income Appears To Play Role In Amount Of Time Between Onset Of Psychosis And Receipt Of Services To Treat Patients With First-Episode Psychosis, Study Suggests

Psychiatric News (1/17) reports, “An individual’s personal income appears to play a role in the amount of time between the onset of psychosis and receipt of services to treat first-episode psychosis…suggests a study.” Investigators came to this conclusion after analyzing “data from patients enrolled in two first-episode treatment programs—the Program for Specialized Treatment Early in Psychosis…in New Haven, Conn., and the Prevention and Recovery in Early Psychosis…in Boston.” The findings were published in Psychiatric Services. “Lower personal income was significantly associated with younger age, fewer years of education, Black race, and longer Duration of Untreated Psychosis (DUP). Personal income predicted DUP beyond the effects of age, race, and early psychosis detection.”

Related Links:

— “Lower Income Associated With Greater Treatment Delays for People With First-Episode Psychosis,” Psychiatric News, January 17, 2024